{
    "clinical_study": {
        "@rank": "141348", 
        "arm_group": {
            "arm_group_label": "Use of Levita Magnetics Grasper", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the Levita Magnetic Grasper Device Safety and\n      Performance in Laparoscopy."
        }, 
        "brief_title": "Levita Magnetic Grasper Device Safety and Performance Study", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Benign Gallbladder Disease", 
        "condition_browse": {
            "mesh_term": "Gallbladder Diseases"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient is between 18 and 60 years of age\n\n               -  Undergoing elective cholecystectomy due to:\n\n               -  Cholelithiasis (Gallbladder stones < 2.5cm in longer measurement (length or\n                  width))\n\n               -  Gallbladder polyps as assessed by ultrasound\n\n               -  Absence of non-correctable coagulopathy (INR < 1.4 or, platelet count of <\n                  50,000/mcl)\n\n               -  Patient has a body mass index (BMI) \u2264 35 kg/m2 and over 20\n\n               -  Patient, or authorized representative, signs a written Informed Consent form to\n                  participate in the study, prior to any study mandated determinations or\n                  procedure\n\n        Exclusion Criteria:\n\n          -  Emergency presentation with acute gallbladder disease\n\n               -  Pancreatitis\n\n               -  Jaundice\n\n               -  Scleroatrophic gallbladder as shown by ultrasound\n\n               -  Biliary tract stones diagnosed before or during surgery\n\n               -  Acute cholecystitis\n\n               -  Gallbladder Empyema\n\n               -  Ongoing peritoneal dialysis\n\n               -  Previous abdominal surgery or laparotomy (presence of any previous upper\n                  umbilical incision)\n\n               -  Presence of umbilical hernia or previous umbilical hernia\n\n               -  American Society of Anesthesiologists (ASA) score of III or IV\n\n               -  Patient is undergoing treatment for chronic pain of any origin\n\n               -  Significant comorbidities: cardiovascular, neuromuscular, chronic obstructive\n                  pulmonary disease, and urological disease (renal failure)\n\n               -  Patients with signs of gallbladder perforation diagnosed by ultrasound\n\n               -  Suspicion of biliary cancer\n\n               -  Patients with severe peritonitis\n\n               -  Contraindications to pneumoperitoneum\n\n               -  Known allergy to paracetamol or NSAIDs\n\n               -  Patients with metallic implants (such as pacemakers, prosthesis, etc)\n\n               -  Previously diagnosed or suspected of having a history of choledocholithiasis\n                  based on any alterations in plasma hepatic enzymes\n\n               -  Has a biliary tract > 7mm in size as determined by ultrasound\n\n               -  Has a gallbladder wall thickness that is > 5mm\n\n               -  Diabetic Blood coagulation issues\n\n               -  Has signs of hepatic endocrinology (i.e: cirrhosis, liver failure, increase in\n                  liver enzymes, etc.)\n\n               -  History of endoscopic papillotomy (i.e: Preoperative indication of endoscopic\n                  retrograde cholangiopancreatography (ERCP)\n\n               -  Patient is pregnant or wishes to become pregnant during the length of study\n                  participation or lactation\n\n               -  Patient is not likely to comply with the follow-up evaluation schedule\n\n               -  Patient is participating in a clinical trial of another investigational drug or\n                  device\n\n               -  Patient is mentally incompetent or a prisoner\n\n               -  Known or suspected drug or alcohol abuse\n\n               -  Patient has systemic infection or evidence of any surgical site infection\n                  (superficial or organ space)\n\n               -  Patient has compromised immune system or autoimmune disease (WBC < 4000 or >\n                  20,000), including prior or pending treatment for HIV or Hep. C\n\n               -  Patient intra-operatively needs an additional surgery while undergoing elective\n                  cholecystectomy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02049983", 
            "org_study_id": "LEV-TP-0010", 
            "secondary_id": "Grant 13IEAT-20911"
        }, 
        "intervention": {
            "arm_group_label": "Use of Levita Magnetics Grasper", 
            "intervention_name": "Use of Levita Magnetics Grasper", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 29, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Ignacio Robles, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Santiago", 
                        "country": "Chile"
                    }, 
                    "name": "Hospital Salvador"
                }, 
                "investigator": {
                    "last_name": "Ignacio Robles, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Marcelo Vivanco, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Santiago", 
                        "country": "Chile"
                    }, 
                    "name": "Hospital Padre Hurtado"
                }, 
                "investigator": {
                    "last_name": "Marcelo Vivanco, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Chile"
        }, 
        "number_of_arms": "1", 
        "official_title": "Levita Magnetic Grasper Device Safety and Performance Study", 
        "overall_contact": {
            "email": "aforro@linceconsulting.com", 
            "last_name": "Amy Forrro", 
            "phone": "(508) 254-1005"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Chile: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Absence of any damage or side effect to the patient directly produced by the device during the surgery", 
                "measure": "Safety", 
                "safety_issue": "Yes", 
                "time_frame": "One month"
            }, 
            {
                "description": "Ability to adequately mobilize the organ during the surgery", 
                "measure": "Feasibility", 
                "safety_issue": "No", 
                "time_frame": "Intra-operative"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02049983"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Levita Magnetics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Levita Magnetics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}